cadonilimab
akesobio
['ak104', 'cadonilimab', 'akeso']
akeso announces oral presentation featuring promising clinical data of cadonilimab (pd-1/ctla-4 bsabs, ak104) for the first-line treatment of r/m cervical cancer at asco 2022 #organic #health #food #cooking
Organic Holistic Sustainable Collective